Valuation
- Market cap
- 4,749,000
- Revenue TTM
- $0
- Net income TTM
- $-18,060,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.01
Trading
- Volume
- 896,800
- Avg volume
- 224,766
- Day's range
- $2.84 – $3.75
- Shares out
- 1,588,000
- Stochastic %K
- 40%
- Beta
- 1.19
- Analysts
- Hold
- Price target
- $36.00
Company profile
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of...
Show more
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Website
- https://www.grid-ai.com
- Address
- 91 George St, Edinburgh, United Kingdom
Latest news
No headlines yet.
